Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists.
about
The CK1 Family: Contribution to Cellular Stress Response and Its Role in CarcinogenesisDynamic regulation of the COP9 signalosome in response to DNA damageMeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?Targeting G protein coupled receptor-related pathways as emerging molecular therapiesRecent advances in enrichment and separation strategies for mass spectrometry-based phosphoproteomicsRegulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyondA Fluorescent Live Imaging Screening Assay Based on Translocation Criteria Identifies Novel Cytoplasmic Proteins Implicated in G Protein-coupled Receptor Signaling PathwaysThe Crystal Structure of Six-transmembrane Epithelial Antigen of the Prostate 4 (Steap4), a Ferri/Cuprireductase, Suggests a Novel Interdomain Flavin-binding SitePost-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and diseaseBiased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanismsEvolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11Predicting Kinase Activity in Angiotensin Receptor Phosphoproteomes Based on Sequence-Motifs and InteractionsProbing the stoichiometry of β2-adrenergic receptor phosphorylation by targeted mass spectrometryQuantitative phosphoproteomics of CXCL12 (SDF-1) signaling.Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).Asymmetric mRNA localization contributes to fidelity and sensitivity of spatially localized systemsArrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.Functional selectivity in adrenergic and angiotensin signaling systems.M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1.Β-arrestin: a signaling molecule and potential therapeutic target for heart failure.A Phospho-SIM in the Antiviral Protein PML is Required for Its Recruitment to HSV-1 Genomes.The β-blocker Nebivolol Is a GRK/β-arrestin biased agonistA phosphorylation switch on RbBP5 regulates histone H3 Lys4 methylation.The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling network.Delineation of a conserved arrestin-biased signaling repertoire in vivo.Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signalingAngiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytesCommunication between the N and C termini is required for copper-stimulated Ser/Thr phosphorylation of Cu(I)-ATPase (ATP7B).Mitotic Control of Planar Cell Polarity by Polo-like Kinase 1Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.Effective correction of experimental errors in quantitative proteomics using stable isotope labeling by amino acids in cell culture (SILAC)International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Informatic deconvolution of biased GPCR signaling mechanisms from in vivo pharmacological experimentation.Cardiac mitochondrial matrix and respiratory complex protein phosphorylationPhosphorylation of serine 51 regulates the interaction of human DNA ligase I with replication factor C and its participation in DNA replication and repair.Exploring G protein-coupled receptor signaling networks using SILAC-based phosphoproteomicsTherapeutic potential of β-arrestin- and G protein-biased agonists.Cdc7-dependent and -independent phosphorylation of Claspin in the induction of the DNA replication checkpointAngiotensin II regulates microRNA-132/-212 in hypertensive rats and humans.
P2860
Q21129297-CD6D4ED7-0A3B-462E-85D2-B620AEDB5195Q24319983-6D1C6B3B-A3A0-4FE1-998E-E24D15AF6832Q26824983-1559FDA7-7FCC-49E8-A565-C0AB01D4D6D7Q26829964-724E8C8F-65F8-438A-9764-CA44D91A803AQ26852864-CBBFB282-07E9-4116-9A81-E3B7C1809921Q26859368-87116E5F-0266-40C1-884C-DB8A222EDD85Q27311653-00B1B240-5355-44D0-B0DD-87E763195C5EQ27678472-C89C464D-5493-45F9-92FA-3C4ED2599E7BQ28088517-2D6DD41A-698C-45A1-8FF2-B06D601D4ACDQ28476374-3737BCBB-1B28-4579-A096-7A7138D664E5Q28608369-1DD26348-9685-4A41-93E2-7C4A32A43458Q30002306-621E3A55-8253-4A1C-A092-C5E089F99DE1Q33616665-0ACADE82-F3FD-42C0-873F-56D680C06B6DQ34031600-4948CD7F-F1EF-4271-8EA6-C03674E5F262Q34093722-95895765-E603-4028-9F10-61297529C38AQ34205647-F10B04B3-7BDE-4071-8F4A-E2B6CC3EDDB7Q34249203-A8B177C3-796E-4C9D-B14C-539805139891Q34359586-1F7B80E4-F338-4CD6-97F7-BEDF0CA1EAD2Q34397201-D0086A6C-96FF-4C34-A26F-4424DAED1848Q34716806-DFCC6A96-113D-4B9E-B131-62F83300D8C5Q34774721-1D02B47A-10CB-4A0C-901D-8DA1553CC9BDQ34972784-AF88BC88-BD64-416A-8D29-25F13EEF9611Q34981623-851895CC-BC9B-4DCD-BEC1-A71FA63C6E3AQ35011083-0D4412E3-98D2-433A-BC74-0970EA8307A0Q35198039-36764064-14CE-474D-8367-E7616ACAE696Q35201347-9EDA06F3-396A-4766-8075-CA8A71E30F73Q35216489-DE5D03B5-EFE7-4CD4-A3D3-ACD9DCAFF0BDQ35580770-F918F45B-A500-4C66-92D4-81459EBFD23BQ35640283-16DDE463-B117-4660-B82C-5EACBAECA0C3Q35913650-4F143C10-71B3-491A-B8D2-EC99F14422E3Q35999789-A111E9B7-9F78-431F-885E-43B1DECF26C2Q36088055-7685CE25-EFC1-4F34-89E6-CD4DE7313C28Q36241932-78FF6ECD-95E3-4052-BFB9-0DDC0689D980Q36284673-B69159E4-2F63-4BFA-B571-B6FCB1C15AE5Q36312517-5BED1AE2-AB86-47AD-80A7-CE1F40A54187Q36347649-921A65A0-9B08-4288-B167-594DEFF4AF13Q36418560-76210FF1-DCC7-452D-9A62-54647D9ACC54Q36773331-74CCBAC3-EAF5-4DDF-8387-FE28B2CF2020Q36923333-E0C9AFB5-4D26-4A33-84E5-54405B05E6F8Q37007126-98E2E5FE-A57B-470A-9912-8AD5ED08DAC8
P2860
Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Quantitative phosphoproteomics ...... sing full and biased agonists.
@ast
Quantitative phosphoproteomics ...... sing full and biased agonists.
@en
Quantitative phosphoproteomics ...... sing full and biased agonists.
@nl
type
label
Quantitative phosphoproteomics ...... sing full and biased agonists.
@ast
Quantitative phosphoproteomics ...... sing full and biased agonists.
@en
Quantitative phosphoproteomics ...... sing full and biased agonists.
@nl
prefLabel
Quantitative phosphoproteomics ...... sing full and biased agonists.
@ast
Quantitative phosphoproteomics ...... sing full and biased agonists.
@en
Quantitative phosphoproteomics ...... sing full and biased agonists.
@nl
P2093
P2860
P50
P1476
Quantitative phosphoproteomics ...... sing full and biased agonists.
@en
P2093
Christina Lyngsø
Jakob L Hansen
Rikke Bøgebo
Steen Gammeltoft
Søren P Sheikh
Uzma Sarwar
P2860
P304
P356
10.1074/MCP.M900550-MCP200
P577
2010-04-02T00:00:00Z